Recurrence of hepatitis C virus genotype-4 infection following orthotopic liver transplantation: Natural history and predictors of outcome
| Autor: | Mohammed Al Saghier, Khalil Alawi, Hamad Al Bahili, Mohammed Al Sofayan, Y. Kamel, Ahmed Al-Jedai, Hatem Khalaf, Ayman A. Abdo, Yasser Al Shiek, Hazem Mohamed, Mohammed Al Sebayel, Hatim Mudawi, Waleed Al Hamoudi, Ahmed Helmy |
|---|---|
| Rok vydání: | 2009 |
| Předmět: |
Adult
Graft Rejection Liver Cirrhosis Male medicine.medical_specialty Genotype medicine.medical_treatment Saudi Arabia lcsh:Medicine Hepacivirus Liver transplantation Gastroenterology Statistics Nonparametric Recurrence Internal medicine medicine Humans Survival analysis Analysis of Variance Chi-Square Distribution business.industry lcsh:R General Medicine Hepatitis C Middle Aged Viral Load medicine.disease Survival Analysis Liver Transplantation Natural history Transplantation surgical procedures operative Immunology Original Article Female business Viral load Chi-squared distribution |
| Zdroj: | Annals of Saudi Medicine, Vol 29, Iss 2, Pp 91-97 (2009) Annals of Saudi Medicine |
| ISSN: | 0975-4466 0256-4947 |
| Popis: | Background and Objectives: There are few reports on hepatitis C virus genotype 4 (HCV-4) recurrences after orthotopic liver transplantation (OLT). Therefore, we undertook a study to determine the epidemiological, clinical and virological characteristics of patients with biopsy-proven recurrent HCV infection and analyzed the factors that influence recurrent disease severity. We also compared disease recurrence and outcomes between HCV-4 and other genotypes. Patients and Methods: All patients who underwent OLT (locally or abroad) for HCV related hepatic cir-- rhosis from 1991 to 2006 and had recurrent HCV infection were identified. Clinical, laboratory and pathological data before and after OLT were collected and analyzed. Results: Of 116 patients who underwent OLT for hepatitis C, 46 (39.7%) patients satisfied the criteria of recur--rent hepatitis C. Twenty-nine (63%) patients were infected with HCV genotype 4. Mean (SD) for age was 54.9 (10.9) years. Nineteen of the HCV genotype 4 patients (65.5%) were males, 21 (72.4%) received deceased donor grafts, and 7 (24.1%) developed> 1 acute rejection episodes. Pathologically, 7 (24.1%) and 4 (13.8%) patients had inflammation grade 3-4 and fibrosis stage 3-4, respectively. Follow-up biopsy in 9 (31%) HCV genotype 4 patients showed stable, worse and improved fibrosis stage in 5, 2 and 2 patients, respectively. Of the 7 patients in the recurrent HCV group who died, 6 were infected with genotype 4 and 4 of them died of HCV-related disease. Conclusion: This analysis suggests that HCV recurrence following OLT in HCV-4 patients is not significantly different from its recurrence for other genotypes. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|